|Bid||51.53 x 2200|
|Ask||51.47 x 3100|
|Day's range||50.61 - 51.71|
|52-week range||33.36 - 55.70|
|Beta (5Y monthly)||0.67|
|PE ratio (TTM)||26.04|
|Earnings date||31 Jan 2022 - 04 Feb 2022|
|Forward dividend & yield||1.56 (3.98%)|
|Ex-dividend date||29 Jul 2021|
|1y target est||46.23|
Columbia University professor Meg Fitzgerald speaks with Yahoo Finance Live about the uncertainty surrounding Omicron, the effectiveness (or lack thereof) of travel bans, the demand for booster shots, global vaccination rates, and the strained U.S. health care system.
Should Americans wait to get a potential Omicron-fighting vaccine booster? One epidemiologist says, "Absolutely not."
Yahoo Finance's Anjalee Khemlani runs down President Biden's remarks from today on the COVID-19 Omicron variant and how vaccinations continue to be the best defense against future outbreaks.